Search research articles
Contact Us
Filters
Showing results (491-500 of 573) with videos related to
Page
of 58
Sort By:
Journal of the American Heart Association
|
February 26, 2025
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic Shock
Graham Nichol, Neal W Dickert, Jacob E Moeller, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
International Journal of Cardiology
|
May 31, 2017
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the Society for Cardiovascular Angiography & Interventions
|
April 1, 2026
Baseline ECG Outperforms the Angiogram for Predicting Mortality in COVID-19-Associated STEMI: Insights From the NACMI Registry
Kevin R Bainey, Payam Dehghani, Jyotpal Singh, et al.
Circulation
|
April 17, 2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)
Joshua M Hare, Roberto Bolli, John P Cooke, et al.
The American Journal of Cardiology
|
April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
Page
of 58
Search research articles
Search
Showing results (491-500 of 573) with videos related to
Sort By:
Page
of 58
Journal of the American Heart Association
|
February 26, 2025
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic Shock
Graham Nichol, Neal W Dickert, Jacob E Moeller, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
International Journal of Cardiology
|
May 31, 2017
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the Society for Cardiovascular Angiography & Interventions
|
April 1, 2026
Baseline ECG Outperforms the Angiogram for Predicting Mortality in COVID-19-Associated STEMI: Insights From the NACMI Registry
Kevin R Bainey, Payam Dehghani, Jyotpal Singh, et al.
Circulation
|
April 17, 2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)
Joshua M Hare, Roberto Bolli, John P Cooke, et al.
The American Journal of Cardiology
|
April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
Page
of 58